Taken together, post-AIE treatment with the selective HMGB1 inhibitor glycyrrhizic acid reverses AIE-induced acceleration of AD-associated neuroinflammation, microglial activation, and loss of cholinergic neurons in the adult basal forebrain. The gene discussed is HMGB1; the disease is Alzheimer disease.